AU5126596A - Use of gelatinase b and related enzymes to mobilize hematopo ietic stem cells for blood stem cell transplantation - Google Patents

Use of gelatinase b and related enzymes to mobilize hematopo ietic stem cells for blood stem cell transplantation

Info

Publication number
AU5126596A
AU5126596A AU51265/96A AU5126596A AU5126596A AU 5126596 A AU5126596 A AU 5126596A AU 51265/96 A AU51265/96 A AU 51265/96A AU 5126596 A AU5126596 A AU 5126596A AU 5126596 A AU5126596 A AU 5126596A
Authority
AU
Australia
Prior art keywords
hematopo
ietic
gelatinase
mobilize
cell transplantation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51265/96A
Inventor
Willem Eduard Fibbe
Ghislain Marie-Mathieu Opdenakker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stichting Rega VZW
Universiteit Leiden
Original Assignee
Stichting Rega VZW
Universiteit Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Rega VZW, Universiteit Leiden filed Critical Stichting Rega VZW
Publication of AU5126596A publication Critical patent/AU5126596A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU51265/96A 1995-04-07 1996-04-09 Use of gelatinase b and related enzymes to mobilize hematopo ietic stem cells for blood stem cell transplantation Abandoned AU5126596A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95200891 1995-04-07
EP95200891 1995-04-07
PCT/NL1996/000149 WO1996031233A1 (en) 1995-04-07 1996-04-09 Use of gelatinase b and related enzymes to mobilize hematopoietic stem cells for blood stem cell transplantation

Publications (1)

Publication Number Publication Date
AU5126596A true AU5126596A (en) 1996-10-23

Family

ID=8220181

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51265/96A Abandoned AU5126596A (en) 1995-04-07 1996-04-09 Use of gelatinase b and related enzymes to mobilize hematopo ietic stem cells for blood stem cell transplantation

Country Status (2)

Country Link
AU (1) AU5126596A (en)
WO (1) WO1996031233A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4865540B2 (en) * 2003-04-08 2012-02-01 イエダ リサーチ アンド ディベロップメント カンパニー リミテッド Stem cells with increased sensitivity to chemoattractants and methods of producing and using the same
US8765119B2 (en) * 2004-05-06 2014-07-01 University Of South Florida Treating amyotrophic lateral sclerosis (ALS)with isolated aldehyde dehydrogenase-positive umbilical cord blood cells
WO2015038058A1 (en) * 2013-09-16 2015-03-19 Elastomics Ab Modification of the mechanical properties of living tissue

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES367241A1 (en) * 1968-05-15 1971-07-16 Worthington Biochem Corp Method of preparing purified golagenase that is essentially exempt from proteolic and elastolitic activity. (Machine-translation by Google Translate, not legally binding)

Also Published As

Publication number Publication date
WO1996031233A1 (en) 1996-10-10

Similar Documents

Publication Publication Date Title
AU2730497A (en) Cryopreservation and extensive subculturing of human mesenchymal stem cells
AU1119397A (en) Ex vivo culture of stem cells
AU8128094A (en) (in vitro) amplification of stem cells
AU1644295A (en) Cell culture substrates and methods of use
AU6039696A (en) Myogenic differentiation of human mesenchymal stem cells
AU5566396A (en) Manipulation of plant cell and tissue cultures
AU1002497A (en) Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated
AU1824600A (en) Low oxygen culturing of cells
WO1999011758A3 (en) Cultures of human cns neural stem cells
AU7213294A (en) Methods of culturing and modulating the growth of hair follicular stem cells
AU2001226395A1 (en) Techniques for growth and differentiation of human pluripotent stem cells
AU5969296A (en) Chemically defined medium for human mesenchymal stem cells
AU2469299A (en) Purified populations of stem cells
AU2808397A (en) Skin regeneration using mesenchymal stem cells
CA2333401A1 (en) Reduction of hair growth using inhibitors of matrix metalloproteinases
AU6131198A (en) Isolated mammalian neural stem cells, methods of making such cells, and methods of using such cells
AU3479593A (en) Peptidyl derivatives as inhibitors of interleukin-1beta converting enzyme
AU1478000A (en) (in utero) transplantation of human mesenchymal stem cells
AU3557597A (en) The isolation and culture of fetal cells from peripheral maternal blood
AU2197897A (en) Use of delta-like protein to inhibit the differentiation of stem cells
AU4214799A (en) Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof
AU5126596A (en) Use of gelatinase b and related enzymes to mobilize hematopo ietic stem cells for blood stem cell transplantation
WO2001076507A3 (en) Use of oxygen carriers to improve grafted cell survival in neural transplantation
AU2998300A (en) Genetically altered mesenchymal stem cells and methods of use thereof
AUPO235996A0 (en) Method of cell culture